title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Cathie Wood's Ark Invest Sells Over $25M Worth Of Tesla Shares Amid Boost In Price - NVIDIA  ( NASDAQ:NVDA ) , ARK Genomic Revolution ETF  ( BATS:ARKG ) , ARK Next Generation Internet ETF  ( ARCA:ARKW ) , CRISPR Therapeutics  ( NASDAQ:CRSP ) ",20231005T015433,https://www.benzinga.com/markets/equities/23/10/35100076/cathie-woods-ark-invest-sells-over-25m-worth-of-tesla-shares-amid-boost-in-price,CRSP,0.240489,Somewhat-Bullish,0.344201
"Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday - Allogene Therapeutics  ( NASDAQ:ALLO ) , AlloVir  ( NASDAQ:ALVR ) ",20230413T143842,https://www.benzinga.com/news/23/04/31789935/consolidated-communications-crispr-therapeutics-and-other-big-stocks-moving-higher-on-thursday,CRSP,0.277433,Neutral,0.008521
"Ark Innovation ETF Trades: Sells $5M In CRISPR Therapeutics, Adds Stake In EXACT Sciences, Pacific Biosciences of California",20220805T043210,https://www.benzinga.com/news/22/08/28369047/cathie-wood-run-ark-innovation-etf-sells-crispr-therapeutics-loads-up-on-exact-sciences-corporation,CRSP,0.158519,Somewhat-Bullish,0.299178
"CRISPR Therapeutics AG  ( CRSP )  Reports Q2 Loss, Tops Revenue Estimates",20230807T211506,https://www.zacks.com/stock/news/2133298/crispr-therapeutics-ag-crsp-reports-q2-loss-tops-revenue-estimates,CRSP,0.393977,Neutral,0.133835
CRISPR  ( CRSP )  to Focus on Next-Generation CAR T Pipeline,20231205T181500,https://www.zacks.com/stock/news/2193794/crispr-crsp-to-focus-on-next-generation-car-t-pipeline,CRSP,0.233556,Neutral,0.085501
CRISPR  ( CRSP )  Rises More Than 40% in Past 3 Months: Here's Why,20231124T165000,https://www.zacks.com/stock/news/2189212/crispr-crsp-rises-more-than-40-in-past-3-months-heres-why,CRSP,0.303175,Somewhat-Bullish,0.177061
Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term,20241223T124900,https://www.zacks.com/stock/news/2386694/buy-5-genomics-synthetic-biology-stocks-likely-to-soar-in-short-term,CRSP,0.124809,Neutral,0.044541
"Zacks Industry Outlook Highlights Gilead Sciences, CRISPR Therapeutics, ACADIA Pharmaceuticals, Dynavax and Ligand Pharmaceuticals",20231124T141000,https://www.zacks.com/stock/news/2188966/zacks-industry-outlook-highlights-gilead-sciences-crispr-therapeutics-acadia-pharmaceuticals-dynavax-and-ligand-pharmaceuticals,CRSP,0.127795,Neutral,0.105904
5 Biotech Stocks Likely to Thrive as Industry Prospects Look Bright,20231122T130700,https://www.zacks.com/commentary/2187656/5-biotech-stocks-likely-to-thrive-as-industry-prospects-look-bright,CRSP,0.111281,Neutral,0.139072
"Zacks Industry Outlook Highlights CRISPR Therapeutics, Ligand Pharmaceuticals, Theseus Pharmaceuticals and Kala Pharmaceuticals",20230322T113700,https://www.zacks.com/stock/news/2068930/zacks-industry-outlook-highlights-crispr-therapeutics-ligand-pharmaceuticals-theseus-pharmaceuticals-and-kala-pharmaceuticals,CRSP,0.07793,Neutral,0.018332
4 Biotech Stocks to Consider for Your Portfolio in 2023,20230321T153200,https://www.zacks.com/commentary/2068484/4-biotech-stocks-to-consider-for-your-portfolio-in-2023,CRSP,0.053749,Neutral,0.060037
